K2 PRINCIPAL FUND, L.P. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
K2 PRINCIPAL FUND, L.P. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$442,000
-24.8%
58,772
+23.8%
0.05%0.0%
Q1 2022$588,000
-67.5%
47,462
-66.0%
0.05%
-66.0%
Q2 2021$1,808,000
+12.2%
139,499
+25.7%
0.15%
-50.8%
Q1 2020$1,611,000
-28.4%
111,0000.0%0.30%
+56.4%
Q4 2019$2,249,000
+4064.8%
111,000
+825.0%
0.20%
+4775.0%
Q4 2017$54,000
-76.6%
12,000
-67.5%
0.00%
-73.3%
Q3 2017$231,000
-45.4%
36,900
-81.7%
0.02%
-62.5%
Q4 2016$423,000201,5220.04%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders